Multiple sclerosis: Myeloperoxidase immunoradiology improves detection of acute and chronic disease in experimental model

Benjamin Pulli, Lionel Bure, Gregory R. Wojtkiewicz, Yoshiko Iwamoto, Muhammad Ali, Dan Li, Stefan Schob, Kevin Li Chun Hsieh, Andreas H. Jacobs, John W. Chen

研究成果: 雜誌貢獻文章

17 引文 斯高帕斯(Scopus)

摘要

Purpose: To test if MPO-Gd, a gadolinium-based magnetic resonance (MR) imaging probe that is sensitive and specific for the proinflammatory and oxidative enzyme myeloperoxidase (MPO), which is secreted by certain inflammatory cells, is more sensitive than diethylenetriaminepentaacetic acid (DTPA)-Gd in revealing early subclinical and chronic disease activity in the brain in experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis. Materials and Methods: The protocol for animal experiments was approved by the institutional animal care committee. A total of 61 female SJL mice were induced with EAE. Mice underwent MPOGd- or DTPA-Gd-enhanced MR imaging on days 6, 8, and 10 after induction, before clinical disease develops, and during chronic disease at remission and the first relapse. Brains were harvested at these time points for flow cytometric evaluation of immune cell subtypes and immunohistochemistry. Statistical analysis was performed, and P < .05 was considered to indicate a significant difference. Results: MPO-Gd helps detect earlier (5.2 vs 2.3 days before symptom onset, P = .004) and more (3.1 vs 0.3, P = .008) subclinical inflammatory lesions compared with DTPAGd, including in cases in which there was no evidence of overt blood-brain barrier (BBB) breakdown detected with DTPA-Gd enhancement. The number of MPO-Gd-enhancing lesions correlated with early infiltration of MPOsecreting monocytes and neutrophils into the brain (r = 0.91). MPO-Gd also helped detect more lesions during subclinical disease at remission (5.5 vs 1.3, P = .006) and at the first relapse (9.0 vs 2.7, P = .03) than DTPA-Gd, which also correlated well with the presence and accumulation of MPO-secreting inflammatory cells in the brain (r = 0.93). Conclusion: MPO-Gd specifically reveals lesions with inflammatory monocytes and neutrophils, which actively secrete MPO. These results demonstrate the feasibility of detection of subclinical inflammatory disease activity in vivo, which is different from overt BBB breakdown.
原文英語
頁(從 - 到)480-489
頁數10
期刊Radiology
275
發行號2
DOIs
出版狀態已發佈 - 五月 1 2015

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

指紋 深入研究「Multiple sclerosis: Myeloperoxidase immunoradiology improves detection of acute and chronic disease in experimental model」主題。共同形成了獨特的指紋。

  • 引用此

    Pulli, B., Bure, L., Wojtkiewicz, G. R., Iwamoto, Y., Ali, M., Li, D., Schob, S., Hsieh, K. L. C., Jacobs, A. H., & Chen, J. W. (2015). Multiple sclerosis: Myeloperoxidase immunoradiology improves detection of acute and chronic disease in experimental model. Radiology, 275(2), 480-489. https://doi.org/10.1148/radiol.14141495